BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12912948)

  • 41. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity.
    Zhang S; Schafer-Hales K; Khuri FR; Zhou W; Vertino PM; Marcus AI
    Cancer Res; 2008 Feb; 68(3):740-8. PubMed ID: 18245474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
    J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
    Donati V; Fontanini G; Dell'Omodarme M; Prati MC; Nuti S; Lucchi M; Mussi A; Fabbri M; Basolo F; Croce CM; Aqeilan RI
    Clin Cancer Res; 2007 Feb; 13(3):884-91. PubMed ID: 17289881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
    Abraham SC; Wang H; Wang KK; Wu TT
    Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma.
    Yamashita S; Chujo M; Tokuishi K; Anami K; Miyawaki M; Yamamoto S; Kawahara K
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1303-8. PubMed ID: 19818968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer.
    Tzao C; Tsai HY; Chen JT; Chen CY; Wang YC
    Eur J Cancer; 2004 Sep; 40(14):2175-83. PubMed ID: 15341994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer.
    Cao C; Gao R; Zhang M; Amelio AL; Fallahi M; Chen Z; Gu Y; Hu C; Welsh EA; Engel BE; Haura EB; Cress WD; Wu L; Zajac-Kaye M; Kaye FJ
    J Natl Cancer Inst; 2015 Jan; 107(1):358. PubMed ID: 25465874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E; Koering CE; Gilson E
    Clin Cancer Res; 2003 Mar; 9(3):1105-11. PubMed ID: 12631614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer.
    Bonanno L; Zulato E; Pavan A; Attili I; Pasello G; Conte P; Indraccolo S
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanog maintains stemness of Lkb1-deficient lung adenocarcinoma and prevents gastric differentiation.
    Tong X; Chen Y; Zhu X; Ye Y; Xue Y; Wang R; Gao Y; Zhang W; Gao W; Xiao L; Chen H; Zhang P; Ji H
    EMBO Mol Med; 2021 Sep; 13(9):e14795. PubMed ID: 34490726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer.
    Lagoudaki ED; Koutsopoulos AV; Sfakianaki M; Papadaki C; Manikis GC; Voutsina A; Trypaki M; Tsakalaki E; Fiolitaki G; Hatzidaki D; Yiachnakis E; Koumaki D; Mavroudis D; Tzardi M; Stathopoulos EN; Marias K; Georgoulias V; Souglakos J
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alteration of STK11 Expression Associated With Cholangiocarcinoma Progression.
    Sirithawat P; Jusakul A; Kongpetch S; Thanee M; Srichanchara P; Panjaroensak S; Kimawaha P; Janthamala S; Aphivatanasiri C; Techasen A
    In Vivo; 2023; 37(4):1638-1648. PubMed ID: 37369462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opportunities and Challenges of Kava in Lung Cancer Prevention.
    Freeman B; Mamallapalli J; Bian T; Ballas K; Lynch A; Scala A; Huo Z; Fredenburg KM; Bruijnzeel AW; Baglole CJ; Lu J; Salloum RG; Malaty J; Xing C
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer.
    Avilés-Salas A; Díaz-García DA; Lara-Mejía L; Cardona AF; Orozco-Morales M; Catalán R; Hernández-Pedro NY; Rios-Garcia E; Ramos-Ramírez M; Arrieta O
    Curr Oncol; 2022 Dec; 30(1):333-343. PubMed ID: 36661676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early Diagnosis and Screening for Lung Cancer.
    Kadara H; Tran LM; Liu B; Vachani A; Li S; Sinjab A; Zhou XJ; Dubinett SM; Krysan K
    Cold Spring Harb Perspect Med; 2021 Sep; 11(9):. PubMed ID: 34001525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of Recurrence.
    Mitchell KG; Parra ER; Zhang J; Nelson DB; Corsini EM; Villalobos P; Moran CA; Skoulidis F; Wistuba II; Fujimoto J; Roth JA; Antonoff MB;
    Ann Thorac Surg; 2020 Oct; 110(4):1131-1138. PubMed ID: 32442617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma.
    Jacobsen B; Kriegbaum MC; Santoni-Rugiu E; Ploug M
    World J Clin Oncol; 2014 Oct; 5(4):621-32. PubMed ID: 25302166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic effects of eukaryotic coexpression plasmid carrying LKB1 and FUS1 genes on lung cancer in vitro and in vivo.
    Li L; Yu C; Ren J; Ye S; Ou W; Wang Y; Yang W; Zhong G; Chen X; Shi H; Su X; Chen L; Zhu W
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):895-907. PubMed ID: 24659339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.